Skip to content

A study on the mechanism and biomarker of neuroplasticity of tDCS in the treatment of depression

A study on the mechanism and biomarker of neuroplasticity of tDCS in the treatment of depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069634
Enrollment
Unknown
Registered
2023-03-22
Start date
2023-03-31
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Pseudo-stimulus group:Transcranial direct current pseudo-stimulation
Healthy control group:untreated

Sponsors

Lishui Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for patients with depression: (1) Meet the diagnostic criteria of ICD-10 depression; (2) The age ranges from 20 to 50 (3) Hamilton Depression Scale -17 items score >=17 points (4) Education above primary school (5) Those who sign the informed consent. 2. Inclusion criteria of healthy control group: (1) Normal mental examination; (2) Hamilton depression scale 17 items (HAMD-17) score <= 7 points; (3) The age was between 20 and 50 years old, and the variables of age, gender, marriage, education, and social function were basically matched with those of the first-episode depression group; (4) Willing to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with depression: (1) Patients with severe heart, liver and kidney diseases; (2) Patients with other mental disorders; (3) Patients with severe depression or serious suicidal tendencies; (4) Pregnant and lactating women; (5) Patients who had used any antipsychotic drugs in the last 2 weeks, those who had used long-acting antipsychotic drugs in the last 1 month, and those who had received electroconvulsive therapy in the last 3 months. Exclusion criteria for the healthy control group: (1) Serious physical diseases; (2) Mental retardation or mental retardation (IQ<90); (3) Pregnant women; (4) Previous history of mental disorders or family history of mental disorders; (5) A history of psychoactive substance abuse.

Design outcomes

Primary

MeasureTime frame
Depressive symptom;Cortical plasticity;

Countries

China

Contacts

Public ContactGuidong Zhu

Lishui Second People's Hospital

shiweiykq@163.com18157876936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026